Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Hata

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
World Journal of Gastroenterology|August 30, 2005
Recurrent chromosomal rearrangements at bands 8q24 and 11q13 in gastric cancer as detected by multicolor spectral karyotypingYasuhide Yamashita, Kazuhiro Nishida, Takashi Okuda, et al.
Microbiology and Immunology|November 23, 2006
Mycobacterium kumamotonense Sp. Nov. recovered from clinical specimen and the first isolation report of Mycobacterium arupense in Japan: Novel slowly growing, nonchromogenic clinical isolates related to Mycobacterium terrae complexTakayuki Masaki, Kiyofumi Ohkusu, Hiroyuki Hata, et al.
Biochemical and Biophysical Research Communications|November 14, 2018
MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cellsShinya Endo, Nao Nishimura, Yawara Kawano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2010
[Clinical usefulness of serum free light chain measurement in monoclonal gammopathy]Chihiro Shimazaki, Hirokazu Murakami, Morio Sawamura, et al.
Biochemical and Biophysical Research Communications|December 15, 2015
Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cellsShinya Endo, Masayuki Amano, Nao Nishimura, et al.
International Journal of Hematology|November 22, 2015
Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosisChihiro Shimazaki, Shin-Ichi Fuchida, Kenshi Suzuki, et al.
Systematic and Applied Microbiology|January 9, 2007
The dnaJ gene as a novel phylogenetic marker for identification of Vibrio speciesPham Hong Nhung, Mohammad Monir Shah, Kiyofumi Ohkusu, et al.
International Journal of Hematology|November 29, 2014
Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective studyYoshitaka Kikukawa, Hiromichi Yuki, Sinya Hirata, et al.
Blood|December 6, 2012
PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cellsHiromichi Yuki, Shikiko Ueno, Hiro Tatetsu, et al.
Annals of Hematology|April 6, 2016
Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)Shuji Ozaki, Hiroyuki Hata, Masahiro Abe, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
World Journal of Gastroenterology|August 30, 2005
Recurrent chromosomal rearrangements at bands 8q24 and 11q13 in gastric cancer as detected by multicolor spectral karyotypingYasuhide Yamashita, Kazuhiro Nishida, Takashi Okuda, et al.
Microbiology and Immunology|November 23, 2006
Mycobacterium kumamotonense Sp. Nov. recovered from clinical specimen and the first isolation report of Mycobacterium arupense in Japan: Novel slowly growing, nonchromogenic clinical isolates related to Mycobacterium terrae complexTakayuki Masaki, Kiyofumi Ohkusu, Hiroyuki Hata, et al.
Biochemical and Biophysical Research Communications|November 14, 2018
MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cellsShinya Endo, Nao Nishimura, Yawara Kawano, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2010
[Clinical usefulness of serum free light chain measurement in monoclonal gammopathy]Chihiro Shimazaki, Hirokazu Murakami, Morio Sawamura, et al.
Biochemical and Biophysical Research Communications|December 15, 2015
Immunomodulatory drugs act as inhibitors of DNA methyltransferases and induce PU.1 up-regulation in myeloma cellsShinya Endo, Masayuki Amano, Nao Nishimura, et al.
International Journal of Hematology|November 22, 2015
Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosisChihiro Shimazaki, Shin-Ichi Fuchida, Kenshi Suzuki, et al.
Systematic and Applied Microbiology|January 9, 2007
The dnaJ gene as a novel phylogenetic marker for identification of Vibrio speciesPham Hong Nhung, Mohammad Monir Shah, Kiyofumi Ohkusu, et al.
International Journal of Hematology|November 29, 2014
Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective studyYoshitaka Kikukawa, Hiromichi Yuki, Sinya Hirata, et al.
Blood|December 6, 2012
PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cellsHiromichi Yuki, Shikiko Ueno, Hiro Tatetsu, et al.
Annals of Hematology|April 6, 2016
Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)Shuji Ozaki, Hiroyuki Hata, Masahiro Abe, et al.
Pageof 7